扶桑薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/07/12 | 2,728 | 2,728 | 2,709 | 2,714 | -5 | -0.2% | 3,200 |
2017/07/11 | 2,706 | 2,730 | 2,706 | 2,719 | +9 | +0.3% | 3,400 |
2017/07/10 | 2,710 | 2,725 | 2,710 | 2,710 | -7 | -0.3% | 13,000 |
2017/07/07 | 2,742 | 2,748 | 2,717 | 2,717 | -6 | -0.2% | 6,100 |
2017/07/06 | 2,736 | 2,748 | 2,721 | 2,723 | -13 | -0.5% | 5,400 |
2017/07/05 | 2,742 | 2,748 | 2,731 | 2,736 | -12 | -0.4% | 5,200 |
2017/07/04 | 2,753 | 2,770 | 2,735 | 2,748 | -5 | -0.2% | 8,000 |
2017/07/03 | 2,761 | 2,781 | 2,753 | 2,753 | -26 | -0.9% | 7,200 |
2017/06/30 | 2,770 | 2,788 | 2,741 | 2,779 | -6 | -0.2% | 5,900 |
2017/06/29 | 2,802 | 2,802 | 2,776 | 2,785 | +2 | +0.1% | 3,500 |
2017/06/28 | 2,781 | 2,792 | 2,770 | 2,783 | -17 | -0.6% | 4,400 |
2017/06/27 | 2,791 | 2,810 | 2,791 | 2,800 | +9 | +0.3% | 3,800 |
2017/06/26 | 2,787 | 2,800 | 2,785 | 2,791 | +4 | +0.1% | 3,500 |
2017/06/23 | 2,790 | 2,792 | 2,781 | 2,787 | -5 | -0.2% | 2,700 |
2017/06/22 | 2,810 | 2,816 | 2,790 | 2,792 | -14 | -0.5% | 5,900 |
2017/06/21 | 2,849 | 2,850 | 2,802 | 2,806 | -35 | -1.2% | 4,700 |
2017/06/20 | 2,842 | 2,852 | 2,821 | 2,841 | -1 | ±0% | 9,900 |
2017/06/19 | 2,800 | 2,871 | 2,800 | 2,842 | +21 | +0.7% | 9,800 |
2017/06/16 | 2,795 | 2,821 | 2,782 | 2,821 | +35 | +1.3% | 13,700 |
2017/06/15 | 2,781 | 2,813 | 2,780 | 2,786 | +6 | +0.2% | 6,100 |
2017/06/14 | 2,806 | 2,830 | 2,780 | 2,780 | +2 | +0.1% | 6,300 |
2017/06/13 | 2,799 | 2,813 | 2,765 | 2,778 | -11 | -0.4% | 9,300 |
2017/06/12 | 2,788 | 2,815 | 2,788 | 2,789 | -23 | -0.8% | 3,400 |
2017/06/09 | 2,801 | 2,830 | 2,801 | 2,812 | -7 | -0.2% | 7,300 |
2017/06/08 | 2,815 | 2,829 | 2,806 | 2,819 | +21 | +0.8% | 4,500 |
2017/06/07 | 2,810 | 2,860 | 2,797 | 2,798 | +9 | +0.3% | 6,600 |
2017/06/06 | 2,829 | 2,837 | 2,789 | 2,789 | -40 | -1.4% | 3,600 |
2017/06/05 | 2,821 | 2,838 | 2,806 | 2,829 | -16 | -0.6% | 5,800 |
2017/06/02 | 2,832 | 2,850 | 2,793 | 2,845 | +40 | +1.4% | 8,300 |
2017/06/01 | 2,775 | 2,842 | 2,773 | 2,805 | +49 | +1.8% | 6,300 |
2017/05/31 | 2,816 | 2,816 | 2,756 | 2,756 | -82 | -2.9% | 6,500 |
2017/05/30 | 2,849 | 2,849 | 2,838 | 2,838 | -15 | -0.5% | 3,600 |
2017/05/29 | 2,900 | 2,900 | 2,850 | 2,853 | -47 | -1.6% | 5,300 |
2017/05/26 | 2,867 | 2,900 | 2,867 | 2,900 | +33 | +1.2% | 6,800 |
2017/05/25 | 2,909 | 2,909 | 2,859 | 2,867 | -39 | -1.3% | 4,600 |
2017/05/24 | 2,929 | 2,929 | 2,877 | 2,906 | -11 | -0.4% | 4,100 |
2017/05/23 | 2,896 | 2,918 | 2,882 | 2,917 | +21 | +0.7% | 5,100 |
2017/05/22 | 2,930 | 2,930 | 2,896 | 2,896 | -35 | -1.2% | 5,200 |
2017/05/19 | 2,930 | 2,935 | 2,910 | 2,931 | +2 | +0.1% | 8,300 |
2017/05/18 | 2,907 | 2,929 | 2,906 | 2,929 | +19 | +0.7% | 7,600 |
2017/05/17 | 2,879 | 2,910 | 2,876 | 2,910 | +31 | +1.1% | 5,000 |
2017/05/16 | 2,882 | 2,882 | 2,839 | 2,879 | +29 | +1% | 6,600 |
2017/05/15 | 2,862 | 2,919 | 2,840 | 2,850 | -12 | -0.4% | 6,400 |
2017/05/12 | 2,940 | 2,940 | 2,851 | 2,862 | -78 | -2.7% | 10,900 |
2017/05/11 | 2,931 | 2,940 | 2,883 | 2,940 | +8 | +0.3% | 6,000 |
2017/05/10 | 2,874 | 2,932 | 2,874 | 2,932 | +8 | +0.3% | 8,200 |
2017/05/09 | 2,905 | 2,938 | 2,894 | 2,924 | -4 | -0.1% | 11,200 |
2017/05/08 | 2,869 | 2,941 | 2,869 | 2,928 | +59 | +2.1% | 16,700 |
2017/05/02 | 2,862 | 2,883 | 2,862 | 2,869 | +8 | +0.3% | 9,100 |
2017/05/01 | 2,875 | 2,875 | 2,825 | 2,861 | -2 | -0.1% | 2,800 |
1901~
1950
件表示中 / 3687件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
扶桑薬 | 233,100円 | +8.3% | +98.1% | 3.52% | 7.66倍 | 0.53倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ミズホメディ | 149,600円 | +1.2% | -13.9% | 5.68% | 8.82倍 | 1.64倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
アンジェス | 7,100円 | +110.0% | - | 0.00% | - | 11.54倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
ステムリム | 32,000円 | - | - | 0.00% | - | 2.95倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
CANBAS | 102,100円 | - | - | 0.00% | - | 6.53倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム